Join our Team
Evolution Biotechnologies Ltd. is leading the expansion of “green” biological control from its proven applications in agriculture into the high value biomedical sector.
The company is working to develop novel biological control agents targeting house dust mites, a leading cause of and trigger for asthma. Subsequent work will target other arthropod pests with an impact on human health.
Asthma is a major health problem with significant unmet need. 334 million people worldwide suffer from asthma, with more than 400,000 people dying every year. Asthma costs exceed $100 billion in the US and EU alone. Evolution holds patents in worldwide markets protecting its unique technology.
We have now completed recruitment for our expanded operations in the United Kingdom. While we are not actively hiring at present, we are always interested in hearing from scientists with experience in arthropod diseases, in particular with infections of mites.